Extracellular Prolidase (PEPD) Induces Anabolic Processes through EGFR, β1-integrin, and IGF-1R Signaling Pathways in an Experimental Model of Wounded Fibroblasts

Int J Mol Sci. 2021 Jan 19;22(2):942. doi: 10.3390/ijms22020942.

Abstract

The role of prolidase (PEPD) as a ligand of the epidermal growth factor receptor (EGFR) was studied in an experimental model of wound healing in cultured fibroblasts. The cells were treated with PEPD (1-100 nM) and analysis of cell viability, proliferation, migration, collagen biosynthesis, PEPD activity, and the expressions of EGFR, insulin-like growth factor 1 (IGF-1), and β1-integrin receptor including downstream signaling proteins were performed. It has been found that PEPD stimulated proliferation and migration of fibroblasts via activation of the EGFR-downstream PI3K/Akt/mTOR signaling pathway. Simultaneously, PEPD stimulated the expression of β1-integrin and IGF-1 receptors and proteins downstream to these receptors such as FAK, Grb2, and ERK1/2. Collagen biosynthesis was increased in control and "wounded" fibroblasts under PEPD treatment. The data suggest that PEPD-induced EGFR signaling may serve as a new attempt to therapy wound healing.

Keywords: EGFR; IGF-1; PEPD; fibroblasts; prolidase; wound healing; β1-integrin.

MeSH terms

  • Animals
  • Dipeptidases / genetics*
  • Dipeptidases / pharmacology
  • ErbB Receptors / genetics
  • Fibroblasts / drug effects
  • Gene Expression Regulation / drug effects
  • Humans
  • Integrin beta1 / genetics*
  • Mice
  • Receptor, IGF Type 1 / genetics*
  • Signal Transduction / drug effects
  • Skin / drug effects
  • Skin / injuries
  • Skin / metabolism
  • Wound Healing / drug effects
  • Wound Healing / genetics*

Substances

  • IGF1R protein, human
  • Integrin beta1
  • EGFR protein, human
  • ErbB Receptors
  • Receptor, IGF Type 1
  • Dipeptidases
  • proline dipeptidase